Questions

2328. Deputy Ken O'Flynn asked the Minister for Health whether any national respiratory disease monitoring, surveillance, forecasting, winter-planning, population-health management or health-service demand forecasting system currently incorporates prescribing, reimbursement or utilisation data held by the Primary Care Reimbursement Service; if so, to identify each such system, the datasets used, the purpose for which…

2329. Deputy Ken O'Flynn asked the Minister for Health whether the Department of Health, the HSE, the Health Protection Surveillance Centre, the National Clinical Programme for Respiratory Health, the Central Statistics Office, or any other public body has undertaken an assessment of the potential use of Primary Care Reimbursement Service prescribing or reimbursement data as an early-warning indicator for respiratory…

2330. Deputy Ken O'Flynn asked the Minister for Health whether the two System Analysis Reviews identified by the National Ambulance Service as involving ambulance allocation or dispatch delays since 2020 resulted in recommendations, corrective actions, policy changes or service improvements; and if so, to provide details. [43664/26]

2331. Deputy Ken O'Flynn asked the Minister for Health whether the two incidents involving delayed ambulance allocation that were escalated through the Enterprise Risk Register, Serious Incident Management Team or National Incident Management System involved patient death, serious harm, permanent injury or other adverse clinical outcomes; and if they cannot provide details for confidentiality reasons, to outline the …

2332. Deputy Ken O'Flynn asked the Minister for Health whether they are satisfied that the National Ambulance Service does not routinely maintain datasets recording prolonged ambulance allocation delays, longest allocation delays, or correlations between dispatch delays and patient outcomes; and whether any plans exist to introduce such monitoring and reporting arrangements. [43666/26]

2333. Deputy Ken O'Flynn asked the Minister for Health whether they are satisfied that the National Ambulance Service does not maintain a national dataset recording elapsed time between receipt of a 999 call and allocation of an ambulance resource; whether the Minister has requested that such a dataset be established; and if she will make a statement on the matter. [43671/26]

2334. Deputy Ken O'Flynn asked the Minister for Health whether they are satisfied that no national analysis has been conducted examining the relationship between ambulance allocation or dispatch delays and mortality, morbidity, clinical deterioration or other patient outcomes; whether such analysis will now be commissioned; and if she will make a statement on the matter. [43672/26]

2335. Deputy Ken O'Flynn asked the Minister for Health whether they will publish details of the two System Analysis Reviews identified by the National Ambulance Service as having found ambulance allocation or dispatch delays to be contributory factors; and if publication is not possible, the nature of the findings, recommendations and corrective actions arising from those reviews. [43673/26]

2336. Deputy Ken O'Flynn asked the Minister for Health the number of rejected claims recorded under the PCRS in each of the years 2023, 2024, 2025 and to date in 2026 for respiratory medicines including salbutamol, ipratropium products, inhaled corticosteroids and nebuliser products; the number subsequently paid following resubmission; the most common reasons for rejection; and if she will make a statement on the mat…

2337. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has undertaken any analysis, audit, review or monitoring of rejected PCRS claims relating to respiratory medicines since 2023; whether any trends, recurring errors, reimbursement issues or patient-access concerns have been identified; and if she will make a statement on the matter. [43675/26]

2338. Deputy Niamh Smyth asked the Minister for Health if she will outline the free transport supports available to wheelchair-dependent patients attending medical appointments; and if she will make a statement on the matter. [43676/26]

2339. Deputy Pádraig Rice asked the Minister for Health the current status of the Review of Access to Cannabis for Medical Use; the expected timelines for completion; if the review will consider the expansion of the Medical Cannabis Access Programme to additional conditions in line with evolving international clinical practice; and if she will make a statement on the matter. [43679/26]

2340. Deputy Pádraig Rice asked the Minister for Health if her Department has conducted comparative analysis of medicinal cannabis access models across other European jurisdictions, including Germany, Denmark, the Netherlands, and the United Kingdom; if this analysis will inform future policy decisions relating to patient access in Ireland; and if she will make a statement on the matter. [43680/26]

2341. Deputy Pádraig Rice asked the Minister for Health if chronic pain conditions are being considered as part of the ongoing review of access to cannabis for medical use (details supplied); and if she will make a statement on the matter. [43681/26]

2342. Deputy Pádraig Rice asked the Minister for Health if consideration is being given to the development of a structured patient registry or real-world evidence programme as part of the future evolution of the Medical Cannabis Access Programme (details supplied); and if she will make a statement on the matter. [43682/26]

2343. Deputy Pádraig Rice asked the Minister for Health if the review of access to cannabis for medical use is examining barriers to clinician participation in the Medical Cannabis Access Programme, including prescribing pathways, education, and administrative processes; if her Department envisages a future role for general practitioners in supporting continuity of care for patients prescribed medicinal cannabis prod…

2344. Deputy Keira Keogh asked the Minister for Health for an update on the Diabetes Strategy; if it will be delivered in its intended timeframe; if it will be given increased resources to ensure delivery; and if she will make a statement on the matter. [43684/26]

2345. Deputy Pádraig Rice asked the Minister for Health if a paediatric spinal surgery or scoliosis registry previously operated within CHI or the HSE; if it was subsequently removed from use; the reasons for discontinuing the registry despite public funding having been allocated to its development and operation; the governance, implant surveillance and long-term outcome monitoring arrangements that replaced it; if t…

2346. Deputy Pádraig Rice asked the Minister for Health the current status of the equity of access audit relating to paediatric spinal surgery services; the date on which the audit commenced; the reasons for ongoing delays in its completion and publication; if interim findings or recommendations have been provided to her Department, HSE or CHI; the expected publication timeline; and if she will make a statement on th…

2347. Deputy Pádraig Rice asked the Minister for Health if the Health Products Regulatory Authority undertook any review, investigation or regulatory assessment into the use, monitoring and follow-up of MAGEC rods within CHI following international field safety notices and device safety concerns; if any recommendations were issued; if she will publish the findings; and if she will make a statement on the matter. [436…

2348. Deputy Pádraig Rice asked the Minister for Health the dates at which CHI, the HSE and HIQA first became aware that one field safety notice (details supplied) had not been recorded as communicated to parents; the actions subsequently taken; if all affected families were later identified and informed; her views on the governance, disclosure and patient safety issues arising from this; and if she will make a state…

2349. Deputy Pádraig Rice asked the Minister for Health if all experimental, innovative or novel paediatric spinal procedures undertaken within CHI were subject to formal ethics committee review and approval prior to implementation; the governance framework applied to such procedures; if she will publish the relevant policies, approval pathways and oversight arrangements; and if she will make a statement on the matte…

2350. Deputy Pádraig Rice asked the Minister for Health the governance, regulatory and ethical frameworks governing the off-label use of spinal implants and medical devices in paediatric spinal surgery within CHI; if such use is formally recorded, her views on the patient safety and oversight arrangements applying to such practices; and if she will make a statement on the matter. [43690/26]

2351. Deputy Naoise Ó Muirí asked the Minister for Health the position regarding the availability of the omnipod 5 automated insulin delivery system in Ireland; the status of its approval and reimbursement process; and the timeframe for its expected roll out, in view of its availability in other European countries and the growing demand among Irish diabetes patients for access to advanced insulin delivery technologie…

2352. Deputy Niamh Smyth asked the Minister for Health the reason a person (details supplied) cannot get referred to the public health system for a device because of their age. [43711/26]